Literature DB >> 19161934

Safety and efficacy of simultaneous cholecystectomy at Roux-en-Y gastric bypass.

Jin-Jo Kim1, Bruce Schirmer.   

Abstract

BACKGROUND: To date, published reports have shown an increased length of hospital stay and increased morbidity for patients undergoing simultaneous cholecystectomy during Roux-en-Y gastric bypass (RYGB). We hypothesized that our experience would not show such adverse outcomes.
METHODS: All RYGB procedures (n = 752) performed by 1 surgeon at our institution from 1995 to 2006 were reviewed for demographic data, operative data, and postoperative outcomes. A laparoscopic approach (LRYGB) was used for 438 procedures. The data from a prospectively gathered institutional database were retrospectively compared using standard statistical analysis.
RESULTS: Comparing LRYGB with cholecystectomy to LRYGB without cholecystectomy, the operative time was significantly longer (198.4 +/- 61.9 versus 177.7 +/- 57.7 min, P = .001), but the mean hospital stay (3.3 +/- 5.5 versus 2.9 +/- 6.1 d, P = .555), postoperative complication rate (18.3% versus 18.5%, P = .100), and postoperative mortality (0% and .6%, P = 1.000) were not different between the 2 groups. Comparing the open RYGB patients with and without simultaneous cholecystectomy, the operative time was similarly longer (223.4 +/- 63.9 versus 203.5 +/- 57.3 min, P = .005), and the mean hospital stay (5.0 +/- 3.7 versus 4.7 +/- 5.9 d, P = .644), postoperative complication rate (61.4% versus 55.2%, P = .293), and postoperative mortality rate (1.6% versus 2.4%, P = .685) were not different between the 2 groups.
CONCLUSION: Although it took, on average, 20 minutes longer, cholecystectomy can be safely added to RYGB without increasing the hospital stay, postoperative morbidity, or mortality in both laparoscopic and open surgery using comparable operative techniques. We recommend routine simultaneous cholecystectomy be performed for patients with documented gallstones during RYGB.

Entities:  

Mesh:

Year:  2009        PMID: 19161934     DOI: 10.1016/j.soard.2008.06.001

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  15 in total

1.  Concomitant cholecystectomy should be routinely performed with laparoscopic Roux-en-Y gastric bypass.

Authors:  Anna C Weiss; Tazo Inui; Ralitza Parina; Alisa M Coker; Garth Jacobsen; Santiago Horgan; Mark Talamini; David C Chang; Bryan Sandler
Journal:  Surg Endosc       Date:  2014-12-17       Impact factor: 4.584

Review 2.  Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis.

Authors:  Rene Warschkow; Ignazio Tarantino; Kristjan Ukegjini; Ulrich Beutner; Ulrich Güller; Bruno M Schmied; Sascha A Müller; Bernd Schultes; Martin Thurnheer
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

3.  Revision of failed bariatric procedures to Roux-en-Y gastric bypass (RYGB).

Authors:  Mousa A Khoursheed; Ibtisam A Al-Bader; Fahad S Al-asfar; Ali I Mohammad; Mumtaz Shukkur; Hussain M Dashti
Journal:  Obes Surg       Date:  2011-08       Impact factor: 4.129

4.  Gallstones and Bariatric Surgery: To Treat or Not to Treat?

Authors:  Marina Morais; Gil Faria; John Preto; José Costa-Maia
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

5.  Cholecystectomy in Patients Submitted to Bariatric Procedure: A Systematic Review and Meta-analysis.

Authors:  Francisco Tustumi; Wanderley M Bernardo; Marco A Santo; Ivan Cecconello
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

6.  Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008.

Authors:  Mathias Worni; Ulrich Guller; Anand Shah; Mihir Gandhi; Jatin Shah; Dimple Rajgor; Ricardo Pietrobon; Danny O Jacobs; Truls Ostbye
Journal:  Obes Surg       Date:  2012-02       Impact factor: 4.129

7.  Asymptomatic Cholelithiasis and Bariatric Surgery: a Comprehensive Long-Term Analysis of the Risks of Biliary Disease in Patients Undergoing Primary Roux-en-Y Gastric Bypass.

Authors:  Robert M Cunningham; Katherine T Jones; Jason E Kuhn; James T Dove; Ryan D Horsley; Mustapha Daouadi; Jon D Gabrielsen; Anthony T Petrick; David M Parker
Journal:  Obes Surg       Date:  2020-11-23       Impact factor: 4.129

8.  Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity.

Authors:  Jaime Benarroch-Gampel; David R Lairson; Casey A Boyd; Kristin M Sheffield; Vivian Ho; Taylor S Riall
Journal:  Surgery       Date:  2012-09       Impact factor: 3.982

9.  Risk of Biliary Events After Selective Cholecystectomy During Biliopancreatic Diversion with Duodenal Switch.

Authors:  Iswanto Sucandy; Moaz Abulfaraj; Mary Naglak; Gintaras Antanavicius
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

10.  Does concomitant cholecystectomy at time of Roux-en-Y gastric bypass impact adverse operative outcomes?

Authors:  Robert B Dorman; Wei Zhong; Anasooya A Abraham; Sayeed Ikramuddin; Waddah B Al-Refaie; Daniel B Leslie; Elizabeth B Habermann
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.